Physician profile
Ann Cherian
NPI 1487818258
$5,180.38
in general payments reported to CMS, 2019-2025
14 companies · $2,147 in 2025
The $2,147 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $19.40 · 2021: $17.21 · 2022: $564 · 2023: $1,778 · 2024: $492 · 2025: $2,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,758 · Travel and Lodging: $1,570 · Debt Forgiveness: $63.75 · Entertainment: $16.55 · Education: $7.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,758.26 |
| Travel and Lodging | $1,570.49 |
| Debt Forgiveness | $63.75 |
| Entertainment | $16.55 |
| Education | $7.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,861.31 | 2019-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Johnson & Johnson Vision Care, INC. | $1,254.61 | 2024-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $587.76 | 2022-2025 | Infuse, Miebo |
| Sun Pharmaceutical Industries INC. | $306.87 | 2023-2025 | Cequa |
| Carl Zeiss Meditec USA, INC. | $225.35 | 2023-2024 | Cirrus Hd-Oct |
| Coopervision INC. | $211.87 | 2021-2025 | Clariti Contact Lens |
| Ocular Therapeutix, INC. | $125.73 | 2024 | Dextenza |
| Glaukos Corporation | $125.10 | 2025 | Idosetr |
| Dompe US, INC. | $121.95 | 2023 | Oxervate |
| Alexion Pharmaceuticals, INC. | $121.86 | 2025 | Ultomiris |
| Allergan, INC. | $100.83 | 2022 | |
| Optos, INC. | $98.48 | 2022-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Cherian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.